Use of Gilead’s HIV prevention shot rises, but US insurance gaps remain

Investing.com Gold reports: Use of Gilead’s HIV prevention shot rises, but US insurance gaps remain. Full body text was unavailable at ingest time, so this brief is based on headline context.